For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Ataxia-telangiectasia mutated (ATM) is a protein belonging to the P13/P14-kinase family. ATM is an important cell cycle checkpoint kinase and functions to regulate a wide variety of downstream proteins including p53, BRCA1, CHK2, RAD17, RAD9, and NBS1. ATM also plays a key role in double stranded DNA breaks and responds by phosphorylating histone H2AX, thus initiating a complex involving various other proteins that are recruited to the damage site. ATM mutations are associated with neurodegenerative disease and cancer.
The AlphaLISA SureFire UltraHuman Total ATM assay is a sandwich immunoassay for the quantitative detection of total ATM in cellular lysates, using Alpha Technology.
|Experimental Type||In vitro|
|Product Brand Name||AlphaLISA SureFire Ultra|
|Shipping Condition||Blue Ice|
|Therapeutic Area||Central Nervous System, Oncology|
|Unit Size||100 Assay Points|
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...